Slaven Abdovic

Slaven Abdovic

Auto-generated profile, based on publicly available information

Slaven Abdovic

Children's Hospital Zagreb

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Clinical Nutrition
Verified
Journal Article
Closed access
IHIva Hojsak
Iva Hojsak
NSNatalija Snovak
Natalija Snovak
SASlaven Abdović
Slaven Abdović
HSHania Szajewska
Hania Szajewska
ZMZrinjka Mišak
Zrinjka Mišak
SKSanja Kolaček
Sanja Kolaček

1 May 2010 in Pediatrics
Verified
Journal Article
Closed access
PDF file
IHIva Hojsak
Iva Hojsak
SASlaven Abdović
Slaven Abdović
HSHania Szajewska
Hania Szajewska
Milan MiloševićMilan Milošević
Milan Milošević
ŽKŽeljko Krznarić
Željko Krznarić
SKSanja Kolaček
Sanja Kolaček
OBJECTIVE: The incidence of nosocomial infections, predominantly gastrointestinal and respiratory, in children in developed countries is high, ranging from 5% to 44%. There is no effective strategy for preventing these infections. The objective of our study was to investigate the role of Lactobacillus GG (LGG) in preventing nosocomial gastrointestinal and respiratory tract infections at a pediatric hospital. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of 742 hospitalized children. They were randomly allocated to receive for their hospitalization LGG at a dose of 109 colony-forming units in 100 mL of a fermented milk product (LGG group, n = 376) or placebo that was the same postpasteurized fermented milk product without LGG (placebo group, n = 366). RESULTS: In the LGG group, compared with the placebo group, we found a significantly reduced risk for gastrointestinal infections (relative risk [RR]: 0.40 [95% confidence interval (CI): 0.25–0.70]; number needed to treat: 15 [95% CI: 9–34)], respiratory tract infections (RR: 0.38 [95% CI: 0.18–0.85]; number needed to treat: 30 [95% CI: 16–159]), vomiting episodes (RR: 0.5 [95% CI: 0.3–0.9]), diarrheal episodes (RR: 0.24 [95% CI: 0.10–0.50]), episodes of gastrointestinal infections that lasted >2 days (RR: 0.40 [95% CI: 0.25–0.70]), and episodes of respiratory tract infections that lasted >3 days (RR: 0.4 [95% CI: 0.2–0.9]). Groups did not differ in hospitalization duration (P = .1). CONCLUSIONS: LGG administration can be recommended as a valid measure for decreasing the risk for nosocomial gastrointestinal and respiratory tract infections in pediatric facilities.

1 December 2013 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
SASlaven Abdovic
Slaven Abdovic
APAna Mocic Pavic
Ana Mocic Pavic
Milan MiloševićMilan Milošević
Milan Milošević
MPMladen Persic
Mladen Persic
ISIrena Senecic-Cala
Irena Senecic-Cala
SKSanja Kolacek
Sanja Kolacek
To assess the reliability and validity of IMPACT-III (HR), a disease-specific, health-related quality of life instrument in Croatian children with inflammatory bowel disease. In a multicenter study, 104 children participated in a validation study of IMPACT-III (HR) cross-culturally adapted for Croatia. Factor analysis was used to determine optimal domain structure for this cohort, analysis of Cronbach's alpha coefficients to test internal reliability, ANOVA to assess discriminant validity, and correlation with Pediatric Quality of Life Inventory, Version 4.0 (PedsQL) using Pearson correlation coefficients to assess concurrent validity. Cronbach's alpha for the IMPACT-III (HR) total score was 0.92. The most robust factor solution was a 5-domain structure: Symptoms, Concerns, Socializing, Body Image, and Worry about Stool, all of which demonstrated good internal reliability (α=0.60-0.89), but two items were dropped to achieve this. Discriminant validity was demonstrated by significant differences (P<0.001) in mean IMPACT-III (HR) scores between quiescent and mild or moderate-severe disease activity groups for total (148 vs. 139 or 125) and following factor scores: Symptoms (84 vs. 71 or 61), Socializing (91 vs. 83 or 76), and Worry about Stool (significant only between quiescent and moderate-severe groups, 90 vs. 62, respectively). Concurrent validity of IMPACT-III (HR) with PedsQL showed significant correlation, which was strongest when similar domains were compared. IMPACT-III (HR) appears to be useful tool to measure health-related quality of life in Croatian children with Crohn's disease and ulcerative colitis.

4 December 2018 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
SAS. Abdovic
S. Abdovic
MCM. Cuk
M. Cuk
NCN. Cekada
N. Cekada
Milan MiloševićMilan Milošević
Milan Milošević
AGA. Geljic
A. Geljic
ZBZ. Bahtijarevic
Z. Bahtijarevic

1 April 2015 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
SASlaven Abdovic
Slaven Abdovic
APAna Mocic Pavic
Ana Mocic Pavic
Milan MiloševićMilan Milošević
Milan Milošević
MPMladen Persic
Mladen Persic
ISIrena Senecic-Cala
Irena Senecic-Cala
SKSanja Kolacek
Sanja Kolacek
Inflammatory bowel disease (IBD) presents a growing medical and epidemiological problem. In respect to patients, health-related quality of life (HRQOL) emerged as informative means to evaluate the impact of disease burden on health. The Short Health Scale (SHS), a disease-specific HRQOL instrument with only 4 questions (symptoms, functioning, worry, and general well-being), was demonstrated as valid, reliable, and responsive in adults. Aim of this study was to assess its psychometric properties in children with IBD.

1 February 2013 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
ZMZrinjka Mišak
Zrinjka Mišak
IHIva Hojsak
Iva Hojsak
OJOleg Jadrešin
Oleg Jadrešin
AKAlemka Jaklin Kekez
Alemka Jaklin Kekez
SASlaven Abdović
Slaven Abdović
SKSanja Kolaček
Sanja Kolaček